PALI

Palisade Bio, Inc.

Insider Trades

NameValueActionPriceCurrent Price
Jones Mitchell LawrenceChief Medical Officer
$3.5k2k shares
SellFeb 12, 2026
$1.75
--
Finley John DavidDirector, Officer: CEO, CFO
$6.8k3.9k shares
SellFeb 12, 2026
$1.75
--
Williams Donald AllenDirector
$8.4k5k shares
BuyJan 16, 2026
$1.67
--
Williams Donald AllenDirector
$9.4k5k shares
BuyJan 9, 2026
$1.88
--

News

globenewswire.comPalisade Bio Welcomes Biopharmaceutical Industry Veterans Robert Baltera and Jordan Zwick to its Board of Directorsglobenewswire.comJun 11globenewswire.comPalisade Bio to Present on the Potential of PALI-2108 for Fibrostenotic Crohn's Disease at New York Academy of Sciences Symposiumglobenewswire.comJun 9globenewswire.comPalisade Bio to Participate in the Jefferies Global Healthcare Conferenceglobenewswire.comMay 27globenewswire.comPalisade Bio Reports First Quarter 2026 Financial Results and Highlights Continued Clinical Progress of PALI-2108globenewswire.comMay 12globenewswire.comPalisade Bio Reports First Quarter 2026 Financial Results and Highlights Continued Clinical Progress of PALI-2108globenewswire.comMay 12